Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.
Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Coleman D, Connolly CE, Eusebi V, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Jacquemier J, Lacerda M, Martinez-Penuela J, Munt C, Peterse JL, Rank F, Sylvan M, Tsakraklides V, Zafrani B. Sloane JP, et al. Among authors: drijkoningen r. Virchows Arch. 1999 Jan;434(1):3-10. doi: 10.1007/s004280050297. Virchows Arch. 1999. PMID: 10071228
[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
Sloane JP, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Böcker W, Bussolati G, Connolly CE, De Miguel C, Dervan P, Drijkoningen R, Elston CW, Faverly D, Gad A, Holland R, Jacquemier J, Lacerda M, Lindgren A, Martinez-Peñuela J, Peterse JL, Rank F, Tsakraklides V, de Wolf C, Zafrani B. Sloane JP, et al. Among authors: drijkoningen r. Pathologe. 1997 Jan;18(1):71-88. Pathologe. 1997. PMID: 9157408 German. No abstract available.
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs.
Smeets A, Daemen A, Vanden Bempt I, Gevaert O, Claes B, Wildiers H, Drijkoningen R, Van Hummelen P, Lambrechts D, De Moor B, Neven P, Sotiriou C, Vandorpe T, Paridaens R, Christiaens MR. Smeets A, et al. Among authors: drijkoningen r. Breast Cancer Res Treat. 2011 Oct;129(3):767-76. doi: 10.1007/s10549-010-1265-5. Epub 2010 Nov 30. Breast Cancer Res Treat. 2011. PMID: 21116709
Body mass index and HER-2 overexpression in breast cancer patients over 50 years of age.
Van Mieghem T, Leunen K, Pochet N, De Moor B, De Smet F, Amant F, Berteloot P, Timmerman D, Vanden Bempt I, Drijkoningen R, Wildiers H, Paridaens R, Smeets A, Hendrickx W, Van Limbergen E, Christiaens MR, Vergote I, Neven P. Van Mieghem T, et al. Among authors: drijkoningen r. Breast Cancer Res Treat. 2007 Nov;106(1):127-33. doi: 10.1007/s10549-006-9474-7. Epub 2007 Jan 9. Breast Cancer Res Treat. 2007. PMID: 17211534
Familial tubular breast carcinoma.
Boets A, Van Steen A, Van Ongeval C, Drijkoningen R, Christiaens B. Boets A, et al. Among authors: drijkoningen r. JBR-BTR. 2005 May-Jun;88(3):114-5. JBR-BTR. 2005. PMID: 16038219 No abstract available.
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?
Bonnefoi H, Diebold-Berger S, Therasse P, Hamilton A, van de Vijver M, MacGrogan G, Shepherd L, Amaral N, Duval C, Drijkoningen R, Larsimont D, Piccart M. Bonnefoi H, et al. Among authors: drijkoningen r. Ann Oncol. 2003 Mar;14(3):406-13. doi: 10.1093/annonc/mdg108. Ann Oncol. 2003. PMID: 12598346 Free article. Clinical Trial.